. Author manuscript; available in PMC: 2012 Jan 12.

Published in final edited form as: Osteoarthritis Cartilage. 2010 Sep 17;18(12):1608–1619. doi: 10.1016/j.joca.2010.09.004

Table 6.

Immunohistochemical Scores.

IHC Scores	KLD		KLD+CF		KLD+CF+BMSCs		Two-way p-values
Feature	treated	untreated	treated	untreated	treated	untreated	Two-way p-values
I. Aggrecan	2.7 (1.7, 3.6) n=6	2.2 (1.2, 3.1), p=0.526, n=6	3.3 (2.4, 4.3) n=6	2.3 (1.4, 3.3), p=0.041, n=6	2.6 (1.7, 3.5) n=7	1.9 (1.0, 2.7), p=0.253, n=7	TXT: 0.056 Group: 0.384 TXT*Group: 0.857
II. Collagen I	2.7 (1.5, 3.9) n=6	3.0 (1.8, 4.2), p=0.638, n=6	2.8 (1.5, 4.1) n=5	3.3 (2.1, 4.5), p=0.528, n=6	2.8 (1.6, 4.0) n=6	3.0 (1.8, 4.2), p=0.858, n=6	TXT: 0.471 Group: 0.919 TXT*Group: 0.950
III. Collagen II	3.2 (2.0, 4.3) n=6	1.3 (0.2, 2.5), p=0.028, n=6	3.3 (2.1, 4.5) n=5	2.2 (1.0, 3.3), p=0.110, n=6	2.2 (1.0, 3.3) n=6	1.2 (0.0, 2.3), p=0.144, n=6	TXT: 0.001 Group: 0.293 TXT*Group: 0.551

One-way p-values for within group comparisons are listed in the untreated columns. Two-way p-values for differences among groups are in a separate column (TXT = treatment, Group = group, TXT*Group = interaction term). Mean and confidence intervals calculated during two-way analysis are shown.